Clinical Trial Update: First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease [Phase 2]

View source ↗

Summary

First-in-human Phase 2 trial of the MiStent Drug-Eluting Stent for coronary artery disease has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• MiStent Drug Eluting Stent

Snippet

Sponsor: Micell Technologies | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-06-12